Patel, Kush M.
Zhang, Jingwen
Marsden, Justin
Bays, Chloe
Mauldin, Patrick D.
Schreiner, Andrew D.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK K23DK118200, R03DK129558)
Article History
Received: 25 June 2024
Accepted: 18 August 2024
First Online: 20 September 2024
Declarations
:
: All authors report no conflicts of interest with this work. Dr. Schreiner has previously consulted for Pfizer and Novo Nordisk.
: This study (Pro00056541) involves human participants and was approved by the Institutional Review Board at the Medical University of South Carolina (MUSC).